Ondansetron Injection
Product Images NDC 55154-2876

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 55154-2876). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

7d1c9756 013d 4888 Addf 7670da77b884 00

7d1c9756 013d 4888 Addf 7670da77b884 00
The text describes the product "ONDANSETRON INJECTION" which is a sterile 4mg/2mL solution for intravenous or intramuscular injection. It is supplied in single-dose vials and contains ondansetron hydrochloride dyhydrate along with other buffer ingredients. The product insert needs to be referred to for dosage, administration, precautions, and warning information. The vials should be protected from light and stored at controlled room temperature. This product is intended for institutional use only and should be kept out of the reach of children. It is manufactured by West-Ward in Eatontown, NJ, USA and distributed by Cardinal Health in Dublin, OH, USA under the registered trademarks of Novation and NOVAPLUS.*
FDA Label Image

Structural Formula (Ondansetron Injection Usp Novaplus 1)

Structural Formula (Ondansetron Injection Usp Novaplus 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.